Solventum Reports Second Quarter 2026 Financial Results
Article excerpt
Highlighted: the sentence this signal was extracted from
EAGAN, Minn., Aug. 5, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV ) today reported financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Highlights "The Solventum team delivered another quarter of strong execution with results ahead of our expectations while continuing to advance our transformation," said Bryan Hanson, chief executive officer of Solventum. "We remain on track to achieve our long-term objectives as we build a more focused, dedicated MedTech company, well-positioned to create long-term shareholder value." Second Quarter and First Six Months 2026 Financial Results Three months ended June 30, Six Months Ended June 30, (Dollars in millions, except per share amounts) 2026 2025 Year-over-year change 2026 2025 Year over year change Net sales $ 2,209 $ 2,161 2.2 % $ 4,216 $ 4,231 (0.4) % Selling, general and administrative expenses $ 927 $ 772 20.1 % $ 1,754 $ 1,541 13.8 % Research and development expenses $ 178 $ 189 (5.8) % $ 367 $ 381 (3.7) % Operating income margin 8.2 % 9.9 % (170) bps 6.2 % 8.7 % (250) bps Adjusted operating income margin 1 28.4 % 21.9 % 650 bps 24.2 % 20.8 % 340 bps Net income $ 92 $ 90 2.2 % $ 105 $ 227 (53.7) % Diluted earnings per share $ 0.53 $ 0.51 3.9 % $ 0.60 $ 1.30 (53.8) % Adjusted diluted earnings per share 1 $ 2.55 $ 1.69 50.9 % $ 4.02 $ 3.03 32.7 % Net cash provided by (used in) operating activities $...
Keep reading with a free account
The rest of this article, and every signal for Solventum, is in your free account.
